Liver transplant recipient, Osteoporosis
Conditions
Interventions
1:no
3:Caltrate, Calcitriol
4:Caltrate, Calcitriol
Sponsors
The General Hospital of Chinese People's Armed Police Forces
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. More than 3 months after liver transplantation; 2. Age of 20-70 years; 3. Long-term oral FK506 or CSA; 3. Signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients allergic against Caltrate, Calcitriol, Calcitonin, Alendronate and drug components accessories; 2. Patients,who use Active vitamin D in 2 months before the beginning of the study; 3. Patients had treated with bisphosphonates or Strontium salts or sodium fluoride; 4. Pregnancy or lactation; 5. Fracture in 3 months before the beginning of the study; 6. Cancer active stage; 7. Patients with metabolic bone disease, except for osteoporosis; 8. Joint diseases seriously affect the functional tests; 9. Serum calcium level corrected>2.8 mmol/L or <2.0mmol/L; 10. Creatinine clearance rate <35 ml/min; 11. Serum alanine transaminase or total bilirubin are more than twice the normal value; 12. Undergoing physical therapy to improve muscle strength and balance; 13. Life expectancy of less than 6 months; 14. patients with delirium or dementia, who cannot obtain informed consent; 15. Recipients are participating in other clinical studies; 16. Not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bone mineral density;beta-cross laps;P1NP;get-up and walk test;Serum creatinine;Serum alanine transaminase; | — |
Countries
China
Contacts
Public ContactNiu Yujian
Outcome results
None listed